Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 21 of 21 entries
Sorted by: Best Match Show Resources per page
Metabolic syndrome and lifestyle modification.

Reviews in endocrine & metabolic disorders

Takahara M, Shimomura I.
PMID: 25263290
Rev Endocr Metab Disord. 2014 Dec;15(4):317-27. doi: 10.1007/s11154-014-9294-8.

A clustering of metabolic abnormalities such as dyslipidemia, hypertension, and diabetes mellitus, all of which are major risk factors for cardiovascular disease (CVD), occurs more often than by chance. Numerous epidemiological studies, as well as basic researches, have revealed...

Cite
Takahara M, Shimomura I. Metabolic syndrome and lifestyle modification. Rev Endocr Metab Disord. 2014;15(4):317-27doi: 10.1007/s11154-014-9294-8.
Takahara, M., & Shimomura, I. (2014). Metabolic syndrome and lifestyle modification. Reviews in endocrine & metabolic disorders, 15(4), 317-27. https://doi.org/10.1007/s11154-014-9294-8
Takahara, Mitsuyoshi, and Shimomura, Iichiro. "Metabolic syndrome and lifestyle modification." Reviews in endocrine & metabolic disorders vol. 15,4 (2014): 317-27. doi: https://doi.org/10.1007/s11154-014-9294-8
Takahara M, Shimomura I. Metabolic syndrome and lifestyle modification. Rev Endocr Metab Disord. 2014 Dec;15(4):317-27. doi: 10.1007/s11154-014-9294-8. PMID: 25263290.
Copy Download .nbib Format: NLM
Childhood metabolic syndrome: must we define it to deal with it?.

Diabetes care

Weiss R.
PMID: 21525451
Diabetes Care. 2011 May;34:S171-6. doi: 10.2337/dc11-s214.

No abstract available.

Cite
Weiss R. Childhood metabolic syndrome: must we define it to deal with it?. Diabetes Care. 2011;34:S171-6doi: 10.2337/dc11-s214.
Weiss, R. (2011). Childhood metabolic syndrome: must we define it to deal with it?. Diabetes care, 34S171-6. https://doi.org/10.2337/dc11-s214
Weiss, Ram. "Childhood metabolic syndrome: must we define it to deal with it?." Diabetes care vol. 34 (2011): S171-6. doi: https://doi.org/10.2337/dc11-s214
Weiss R. Childhood metabolic syndrome: must we define it to deal with it?. Diabetes Care. 2011 May;34:S171-6. doi: 10.2337/dc11-s214. PMID: 21525451; PMCID: PMC3632157.
Copy Download .nbib Format: NLM
"Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key Symposium.

Journal of internal medicine

Vidal-Puig A, Enerback S.
PMID: 30141829
J Intern Med. 2018 Nov;284(5):447-449. doi: 10.1111/joim.12828.

No abstract available.

Cite
Vidal-Puig A, Enerback S. "Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key Symposium. J Intern Med. 2018;284(5):447-449doi: 10.1111/joim.12828.
Vidal-Puig, A., & Enerback, S. (2018). "Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key Symposium. Journal of internal medicine, 284(5), 447-449. https://doi.org/10.1111/joim.12828
Vidal-Puig, A, and Enerback, S. ""Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key Symposium." Journal of internal medicine vol. 284,5 (2018): 447-449. doi: https://doi.org/10.1111/joim.12828
Vidal-Puig A, Enerback S. "Obesity-associated metabolic complications, the second wave of the tsunami" 14th Key Symposium. J Intern Med. 2018 Nov;284(5):447-449. doi: 10.1111/joim.12828. PMID: 30141829.
Copy Download .nbib Format: NLM
Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents.

Frontiers in endocrinology

Chiesa C, Pacifico L, Xi B, Cadenas-Sanchez C.
PMID: 33250860
Front Endocrinol (Lausanne). 2020 Oct 28;11:613703. doi: 10.3389/fendo.2020.613703. eCollection 2020.

No abstract available.

Cite
Chiesa C, Pacifico L, Xi B, et al. Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents. Front Endocrinol (Lausanne). 2020;11:613703doi: 10.3389/fendo.2020.613703.
Chiesa, C., Pacifico, L., Xi, B., & Cadenas-Sanchez, C. (2020). Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents. Frontiers in endocrinology, 11613703. https://doi.org/10.3389/fendo.2020.613703
Chiesa, Claudio, et al. "Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents." Frontiers in endocrinology vol. 11 (2020): 613703. doi: https://doi.org/10.3389/fendo.2020.613703
Chiesa C, Pacifico L, Xi B, Cadenas-Sanchez C. Editorial: Metabolically Healthy and Unhealthy Obese Children and Adolescents. Front Endocrinol (Lausanne). 2020 Oct 28;11:613703. doi: 10.3389/fendo.2020.613703. eCollection 2020. PMID: 33250860; PMCID: PMC7673443.
Copy Download .nbib Format: NLM
The insulin resistance syndrome and coronary artery disease.

Coronary artery disease

Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, McLean BK, Peragallo-Dittko V, Buse JB, Fonseca VA, Hill JO, Nesto RW, Sunyer FX.
PMID: 12826934
Coron Artery Dis. 2003 Jun;14(4):335-48. doi: 10.1097/01.mca.0000076512.29238.2a.

Insulin resistance is an increasingly common metabolic abnormality characterized by an impaired physiological response to insulin. The constellation of insulin resistance and several other metabolic and vascular disorders is known as the insulin resistance syndrome. The characteristic features of...

Cite
Kendall DM, Sobel BE, Coulston AM, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 2003;14(4):335-48doi: 10.1097/01.mca.0000076512.29238.2a.
Kendall, D. M., Sobel, B. E., Coulston, A. M., Peters Harmel, A. L., McLean, B. K., Peragallo-Dittko, V., Buse, J. B., Fonseca, V. A., Hill, J. O., Nesto, R. W., Sunyer, F. X. (2003). The insulin resistance syndrome and coronary artery disease. Coronary artery disease, 14(4), 335-48. https://doi.org/10.1097/01.mca.0000076512.29238.2a
Kendall, David M, et al. "The insulin resistance syndrome and coronary artery disease." Coronary artery disease vol. 14,4 (2003): 335-48. doi: https://doi.org/10.1097/01.mca.0000076512.29238.2a
Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, McLean BK, Peragallo-Dittko V, Buse JB, Fonseca VA, Hill JO, Nesto RW, Sunyer FX. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 2003 Jun;14(4):335-48. doi: 10.1097/01.mca.0000076512.29238.2a. PMID: 12826934.
Copy Download .nbib Format: NLM
Diabetes, obesity and gut microbiota.

Best practice & research. Clinical gastroenterology

Everard A, Cani PD.
PMID: 23768554
Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83. doi: 10.1016/j.bpg.2013.03.007.

The gut microbiota composition has been associated with several hallmarks of metabolic syndrome (e.g., obesity, type 2 diabetes, cardiovascular diseases, and non-alcoholic steatohepatitis). Growing evidence suggests that gut microbes contribute to the onset of the low-grade inflammation characterising these...

Cite
Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27(1):73-83doi: 10.1016/j.bpg.2013.03.007.
Everard, A., & Cani, P. D. (2013). Diabetes, obesity and gut microbiota. Best practice & research. Clinical gastroenterology, 27(1), 73-83. https://doi.org/10.1016/j.bpg.2013.03.007
Everard, Amandine, and Cani, Patrice D. "Diabetes, obesity and gut microbiota." Best practice & research. Clinical gastroenterology vol. 27,1 (2013): 73-83. doi: https://doi.org/10.1016/j.bpg.2013.03.007
Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013 Feb;27(1):73-83. doi: 10.1016/j.bpg.2013.03.007. PMID: 23768554.
Copy Download .nbib Format: NLM
Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?.

Radiology

Lamb HJ.
PMID: 20959542
Radiology. 2010 Nov;257(2):307-8. doi: 10.1148/radiol.10101346.

No abstract available.

Cite
Lamb HJ. Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?. Radiology. 2010;257(2):307-8doi: 10.1148/radiol.10101346.
Lamb, H. J. (2010). Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?. Radiology, 257(2), 307-8. https://doi.org/10.1148/radiol.10101346
Lamb, Hildo J. "Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?." Radiology vol. 257,2 (2010): 307-8. doi: https://doi.org/10.1148/radiol.10101346
Lamb HJ. Total body fat distribution as part of multiorgan MR imaging: new tool for risk assessment in the metabolic syndrome?. Radiology. 2010 Nov;257(2):307-8. doi: 10.1148/radiol.10101346. PMID: 20959542.
Copy Download .nbib Format: NLM
The chemical pathology of insulin resistance and the metabolic syndrome.

MLO: medical laboratory observer

Harris NS, Winter WE.
PMID: 15536804
MLO Med Lab Obs. 2004 Oct;36(10):20, 22-5.

In this review, we have examined the phenomenon of insulin resistance, a central manifestation of the metabolic syndrome. While it is by no means clear-cut, many new and exciting hypotheses have been proposed to explain this puzzling and enigmatic...

Cite
Harris NS, Winter WE. The chemical pathology of insulin resistance and the metabolic syndrome. MLO Med Lab Obs. 2004;36(10):20, 22-5
Harris, N. S., & Winter, W. E. (2004). The chemical pathology of insulin resistance and the metabolic syndrome. MLO: medical laboratory observer, 36(10), 20, 22-5.
Harris, Neil S, and Winter, William E. "The chemical pathology of insulin resistance and the metabolic syndrome." MLO: medical laboratory observer vol. 36,10 (2004): 20, 22-5.
Harris NS, Winter WE. The chemical pathology of insulin resistance and the metabolic syndrome. MLO Med Lab Obs. 2004 Oct;36(10):20, 22-5. PMID: 15536804.
Copy Download .nbib Format: NLM
Welcome to new insights into 'Metabolic Syndrome'.

Future medicinal chemistry

Matyus P.
PMID: 21428793
Future Med Chem. 2010 Dec;2(12):1719-20. doi: 10.4155/fmc.10.269.

No abstract available.

Cite
Matyus P. Welcome to new insights into 'Metabolic Syndrome'. Future Med Chem. 2010;2(12):1719-20doi: 10.4155/fmc.10.269.
Matyus, P. (2010). Welcome to new insights into 'Metabolic Syndrome'. Future medicinal chemistry, 2(12), 1719-20. https://doi.org/10.4155/fmc.10.269
Matyus, Peter. "Welcome to new insights into 'Metabolic Syndrome'." Future medicinal chemistry vol. 2,12 (2010): 1719-20. doi: https://doi.org/10.4155/fmc.10.269
Matyus P. Welcome to new insights into 'Metabolic Syndrome'. Future Med Chem. 2010 Dec;2(12):1719-20. doi: 10.4155/fmc.10.269. PMID: 21428793.
Copy Download .nbib Format: NLM
Showing 13 to 21 of 21 entries